# Dexmedetomidine Supplemented Analgesia in Patients at High-risk of Obstructive Sleep Apnea

> **NCT04608331** · PHASE4 · COMPLETED · sponsor: **Peking University First Hospital** · enrollment: 152 (actual)

## Conditions studied

- Obstructive Sleep Apnea
- Analgesia
- Dexmedetomidine
- High-flow Nasal Cannula
- Sleep Quality

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04608331
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-29
- **Primary completion:** 2022-08-17
- **Final completion:** 2022-09-20
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2022-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04608331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04608331, "Dexmedetomidine Supplemented Analgesia in Patients at High-risk of Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04608331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*